Jefferies upgraded Enhabit (EHAB) to Buy from Hold with a price target of $9.50, up from $8.25. The company’s announcement of a new contract with UnitedHealth (UNH) that pays it a higher rate than its previous agreement eliminates an overhang and execution risk associated with potential revenue and EBITDA losses, the analyst tells investors in a research note. The firm believes the contract should enable Enhabit to focus more on driving growth rather than plugging the potential earnings hole that would have been caused by a UnitedHealth exit.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EHAB: